Tag: Baidyanath

October 1, 2015 Off

FDA approves Allergan’s Juvederm ultra XC

By Dino Mustafić

Allergan plc has announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market Juvederm ultra XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21.